Frazier Financial Advisors LLC Trims Stake in STERIS plc (NYSE:STE)

Frazier Financial Advisors LLC lessened its position in shares of STERIS plc (NYSE:STE) by 4.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,330 shares of the medical equipment provider’s stock after selling 100 shares during the quarter. Frazier Financial Advisors LLC’s holdings in STERIS were worth $478,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Avalon Trust Co purchased a new stake in shares of STERIS during the fourth quarter worth approximately $30,000. Human Investing LLC purchased a new position in STERIS in the fourth quarter worth $31,000. Anfield Capital Management LLC lifted its holdings in STERIS by 100.0% in the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock valued at $37,000 after acquiring an additional 91 shares during the period. Central Pacific Bank Trust Division grew its stake in shares of STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 76 shares during the period. Finally, Manchester Capital Management LLC increased its holdings in shares of STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after purchasing an additional 137 shares in the last quarter. 94.69% of the stock is owned by institutional investors and hedge funds.

STERIS Stock Performance

NYSE:STE opened at $224.35 on Friday. STERIS plc has a 1-year low of $197.82 and a 1-year high of $248.24. The firm has a 50 day simple moving average of $222.24 and a 200-day simple moving average of $221.63. The firm has a market cap of $22.04 billion, a PE ratio of 47.63 and a beta of 0.92. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40.

STERIS (NYSE:STE) last released its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, equities analysts expect that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were issued a $0.57 dividend. The ex-dividend date was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.02%. STERIS’s dividend payout ratio (DPR) is 48.41%.

Analyst Ratings Changes

Several brokerages recently issued reports on STE. Piper Sandler lifted their price objective on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. JMP Securities reiterated a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Finally, Stephens reissued an “overweight” rating and set a $240.00 price objective on shares of STERIS in a research note on Thursday, February 6th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.